Annual Grant Award Dollars

Investigator Title Sponsor ID Dates Amount
Ralph A Gruppo, MD Hemophilia Comprehensive Care Maternal & Child Health Bureau (Hemophilia Foundation of Michigan) H30MC00015 10/1/1997 - 5/31/2016 $22,000
Ralph A Gruppo, MD Zimmerman Program for the Molecular and Clinical Biology of VWD National Institutes of Health (Medical College of Wisconsin) P01 HL081588 2/1/2013 - 1/31/2017 $200
Ralph A Gruppo, MD MY Life, Our Future: A Hemophilia Genotyping Initiative American Thrombosis & Hemostatis Network ATHN2014MLOF2 2/1/2014 - 9/30/2017 $1,850
Theodosia A Kalfa, MDPHD Rho GTPases in Terminal Erythroid Maturation National Institutes of Health R01 HL116352 9/26/2012 - 6/30/2017 $376,762
Karen Ann Kalinyak, MD The Mid-South Clinical Data Research Network Patient-Centered Outcome Research Inst. (Vanderbilt University) CDRN1306048691 7/1/2014 - 6/30/2016 $525
Patrick McGann, MD-MS Therapeutic Response Evaluation and Adherence Trial: A Prospective Study of Hydroxyurea for Children with Sickle Cell Anemia National Institutes of Health K23 HL128885 9/1/2015 - 5/31/2020 $345,870
Eric Mullins, MD Mechanisms Linking Hemostatic Factors to Neuroinflammatory Disease National Institutes of Health K08 HL105672 8/22/2011 - 7/31/2016 $131,085
Joseph S Palumbo, MD Hemostatic Factors Drive Prostate Cancer Pathogenesis National Institutes of Health R01 CA193678 4/15/2016 - 3/31/2021 $356,850
Joseph S Palumbo, MD Coagulation Factors as modifiers of the Colon Cancer Microenvironment National Institutes of Health R01 CA204058 4/5/2016 - 3/31/2021 $356,850
Lisa M Shook Cincinnati Sickle Cell Project Health Resources & Services Admin (Ohio Department of Health) 03130011SK0512 7/1/1998 - 6/30/2016 $123,469
Lisa M Shook Sickle Cell Treatment Demonstration Program Health Resources & Services Admin U1EMC27863 9/1/2014 - 8/31/2017 $850,000
Russell Ware, MD-PHD Genetic Variants Influencing the Phenotypic Expression of Sickle Cell Anemia Doris Duke Charitable Foundation 2015132 9/1/2015 - 8/31/2018 $162,000
Russell Ware, MD-PHD Prospective Analysis of the Pharmacokinetics and Pharmacodynamics of Hydroxyurea Treatment in Ugandan Children with Sickle Cell Anemia Doris Duke Charitable Foundation 2015190 11/1/2015 - 10/31/2017 $56,000
Russell Ware, MD-PHD Genetic Variants Influencing the Phenotypic Expression of Sickle Cell Anemia Doris Duke Charitable Foundation 2016074 6/1/2016 - 11/30/2017 $70,400
Russell Ware, MD-PHD Endothelialized Microfluidics for Sickle Cell Disease Research & Drug Discovery National Institutes of Health (Emory University) R01 HL121264 1/1/2014 - 12/31/2018 $18,374
Russell Ware, MD-PHD Accurate and Inexpensive Point-of-Care Diagnosis of Sickle Cell Anemia Doris Duke Charitable Foundation (Rice University) R06981 9/1/2013 - 8/31/2016 $48,930
Russell Ware, MD-PHD Genetic Modifiers of Transfusional Iron Overload National Institutes of Health (Baylor College of Medicine) R21 HL123641 8/1/2015 - 7/31/2017 $17,979
Total Annual Grant Award Dollars $2,939,144

Annual Industry Award Dollars

Investigator Industry Sponsor Amount
Eric Mullins, MD Baxter Healthcare Corp. $57,335
Charles T Quinn, MD Amgen, Inc. $291,910
Russell Ware, MD-PHD Biomedomics, Inc. $16,000
Total Annual Industry Award Dollars $365,245